Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Pancreatitis

  Free Subscription


Articles published in Gut

Retrieve available abstracts of 80 articles:
HTML format
Text format



Single Articles


    April 2019
  1. BENITZ S, Straub T, Mahajan UM, Mutter J, et al
    Ring1b-dependent epigenetic remodelling is an essential prerequisite for pancreatic carcinogenesis.
    Gut. 2019 Apr 6. pii: gutjnl-2018-317208. doi: 10.1136/gutjnl-2018-317208.
    PubMed     Text format     Abstract available



  2. Correction: Mechanism of mitochondrial permeability transition pore induction and damage in the pancreas: inhibition prevents acute pancreatitis by protecting production of ATP.
    Gut. 2019 Apr 3. pii: gutjnl-2014-308553.
    PubMed     Text format    


    March 2019
  3. HESSMANN E, Ellenrieder V
    Chromatin remodelling controls pancreatic tissue fate.
    Gut. 2019 Mar 19. pii: gutjnl-2018-317486. doi: 10.1136/gutjnl-2018-317486.
    PubMed     Text format    


  4. GAISER RA, Halimi A, Alkharaan H, Lu L, et al
    Enrichment of oral microbiota in early cystic precursors to invasive pancreatic cancer.
    Gut. 2019 Mar 14. pii: gutjnl-2018-317458. doi: 10.1136/gutjnl-2018-317458.
    PubMed     Text format     Abstract available


  5. LIN JH, Boulling A, Masson E, Cooper DN, et al
    Most unambiguous loss-of-function CPA1 mutations are unlikely to predispose to chronic pancreatitis.
    Gut. 2019 Mar 12. pii: gutjnl-2019-318564. doi: 10.1136/gutjnl-2019-318564.
    PubMed     Text format    


  6. JIANG SH, Zhu LL, Zhang M, Li RK, et al
    GABRP regulates chemokine signalling, macrophage recruitment and tumour progression in pancreatic cancer through tuning KCNN4-mediated Ca(2+) signalling in a GABA-independent manner.
    Gut. 2019 Mar 2. pii: gutjnl-2018-317479. doi: 10.1136/gutjnl-2018-317479.
    PubMed     Text format     Abstract available



  7. Correction: Comprehensive characterisation ofcompartment-specific long non-coding RNAs associated with pancreatic ductaladenocarcinoma.
    Gut. 2019 Mar 2. pii: gutjnl-2017-314353.
    PubMed     Text format    


    February 2019
  8. SINGH S, Hasselluhn MC, Neesse A
    A tangled tale of molecular subtypes in pancreatic cancer.
    Gut. 2019 Feb 27. pii: gutjnl-2018-318086. doi: 10.1136/gutjnl-2018-318086.
    PubMed     Text format    


  9. KATO Y, Azuma K, Someda H, Shiokawa M, et al
    Case of IgG4-associated sclerosing cholangitis with normal serum IgG4 concentration, diagnosed by anti-laminin 511-E8 antibody: a novel autoantibody in patients with autoimmune pancreatitis.
    Gut. 2019 Feb 13. pii: gutjnl-2018-317934. doi: 10.1136/gutjnl-2018-317934.
    PubMed     Text format    


    January 2019
  10. ZHAO Q, Manohar M, Wei Y, Pandol SJ, et al
    STING signalling protects against chronic pancreatitis by modulating Th17 response.
    Gut. 2019 Jan 31. pii: gutjnl-2018-317098. doi: 10.1136/gutjnl-2018-317098.
    PubMed     Text format     Abstract available


  11. MAURER HC, Holmstrom SR, He J, Laise P, et al
    Experimental microdissection enables functional harmonisation of pancreatic cancer subtypes.
    Gut. 2019 Jan 18. pii: gutjnl-2018-317706. doi: 10.1136/gutjnl-2018-317706.
    PubMed     Text format     Abstract available


    December 2018
  12. BAUER CA
    Immunosuppressive betaig-h3 links tumour stroma and dysfunctional T cells in pancreatic cancer.
    Gut. 2018 Dec 7. pii: gutjnl-2018-317735. doi: 10.1136/gutjnl-2018-317735.
    PubMed     Text format    


    November 2018
  13. BANG JY, Varadarajulu S
    Authors reply: treatment strategy for necrotising pancreatitis.
    Gut. 2018 Nov 17. pii: gutjnl-2018-317848. doi: 10.1136/gutjnl-2018-317848.
    PubMed     Text format    


  14. GOEHRIG D, Nigri J, Samain R, Wu Z, et al
    Stromal protein betaig-h3 reprogrammes tumour microenvironment in pancreatic cancer.
    Gut. 2018 Nov 10. pii: gutjnl-2018-317570. doi: 10.1136/gutjnl-2018-317570.
    PubMed     Text format     Abstract available


  15. CONWAY JR, Herrmann D, Evans TJ, Morton JP, et al
    Combating pancreatic cancer with PI3K pathway inhibitors in the era of personalised medicine.
    Gut. 2018 Nov 5. pii: gutjnl-2018-316822. doi: 10.1136/gutjnl-2018-316822.
    PubMed     Text format     Abstract available


    October 2018
  16. LUNA J, Boni J, Cuatrecasas M, Bofill-De Ros X, et al
    DYRK1A modulates c-MET in pancreatic ductal adenocarcinoma to drive tumour growth.
    Gut. 2018 Oct 20. pii: gutjnl-2018-316128. doi: 10.1136/gutjnl-2018-316128.
    PubMed     Text format     Abstract available


  17. KOUTSIOUMPA M, Hatziapostolou M, Polytarchou C, Tolosa EJ, et al
    Lysine methyltransferase 2D regulates pancreatic carcinogenesis through metabolic reprogramming.
    Gut. 2018 Oct 18. pii: gutjnl-2017-315690. doi: 10.1136/gutjnl-2017-315690.
    PubMed     Text format     Abstract available


  18. WANG SC, Nassour I, Xiao S, Zhang S, et al
    SWI/SNF component ARID1A restrains pancreatic neoplasia formation.
    Gut. 2018 Oct 12. pii: gutjnl-2017-315490. doi: 10.1136/gutjnl-2017-315490.
    PubMed     Text format     Abstract available


  19. PUPPA G, Christinat Y, McKee TA
    Towards optimal pancreatic cyst fluid management: the need for standardisation.
    Gut. 2018 Oct 9. pii: gutjnl-2018-317156. doi: 10.1136/gutjnl-2018-317156.
    PubMed     Text format    


    September 2018
  20. NEESSE A, Bauer CA, Ohlund D, Lauth M, et al
    Stromal biology and therapy in pancreatic cancer: ready for clinical translation?
    Gut. 2018 Sep 3. pii: gutjnl-2018-316451. doi: 10.1136/gutjnl-2018-316451.
    PubMed     Text format     Abstract available


    August 2018
  21. RAJ D, Yang MH, Rodgers D, Hampton EN, et al
    Switchable CAR-T cells mediate remission in metastatic pancreatic ductal adenocarcinoma.
    Gut. 2018 Aug 18. pii: gutjnl-2018-316595. doi: 10.1136/gutjnl-2018-316595.
    PubMed     Text format     Abstract available


  22. ROSENDAHL J
    Unfolding the mystery of digestive enzyme misfolding in chronic pancreatitis.
    Gut. 2018 Aug 3. pii: gutjnl-2018-316985. doi: 10.1136/gutjnl-2018-316985.
    PubMed     Text format    


    July 2018
  23. HEGYI E, Sahin-Toth M
    Human CPA1 mutation causes digestive enzyme misfolding and chronic pancreatitis in mice.
    Gut. 2018 Jul 25. pii: gutjnl-2018-315994. doi: 10.1136/gutjnl-2018-315994.
    PubMed     Text format     Abstract available


    June 2018
  24. SCHEPERS NJ, Bakker OJ, Besselink MG, Ahmed Ali U, et al
    Impact of characteristics of organ failure and infected necrosis on mortality in necrotising pancreatitis.
    Gut. 2018 Jun 27. pii: gutjnl-2017-314657. doi: 10.1136/gutjnl-2017-314657.
    PubMed     Text format     Abstract available


    May 2018
  25. IKUTA K, Fukuda A, Ogawa S, Masuo K, et al
    Nardilysin inhibits pancreatitis and suppresses pancreatic ductal adenocarcinoma initiation in mice.
    Gut. 2018 May 24. pii: gutjnl-2017-315425. doi: 10.1136/gutjnl-2017-315425.
    PubMed     Text format     Abstract available



  26. Correction: Metabolic biomarker signature to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis.
    Gut. 2018;67:994.
    PubMed     Text format    


    April 2018
  27. KONG F, Li L, Wang G, Deng X, et al
    VDR signaling inhibits cancer-associated-fibroblasts' release of exosomal miR-10a-5p and limits their supportive effects on pancreatic cancer cells.
    Gut. 2018 Apr 25. pii: gutjnl-2018-316627. doi: 10.1136/gutjnl-2018-316627.
    PubMed     Text format    


  28. ZEISSIG S, Sulk S, Brueckner S, Matthes K, et al
    Severe bleeding is a rare event in patients receiving lumen-apposing metal stents for the drainage of pancreatic fluid collections.
    Gut. 2018 Apr 20. pii: gutjnl-2018-316581. doi: 10.1136/gutjnl-2018-316581.
    PubMed     Text format    


  29. ENEA A, Pizzol A, Pinon M, Cisaro F, et al
    Hereditary pancreatitis in Paediatrics: the causative role of p.Leu104Pro mutation of cationic trypsinogen gene also in young subjects.
    Gut. 2018 Apr 17. pii: gutjnl-2018-316443. doi: 10.1136/gutjnl-2018-316443.
    PubMed     Text format    


  30. SCARPA A, Real FX, Luchini C
    Genetic unrelatedness of co-occurring pancreatic adenocarcinomas and IPMNs challenges current views of clinical management.
    Gut. 2018 Apr 16. pii: gutjnl-2018-316151. doi: 10.1136/gutjnl-2018-316151.
    PubMed     Text format    


  31. HUBERS LM, Vos H, Schuurman AR, Erken R, et al
    Annexin A11 is targeted by IgG4 and IgG1 autoantibodies in IgG4-related disease.
    Gut. 2018;67:728-735.
    PubMed     Text format     Abstract available


    March 2018

  32. European evidence-based guidelines on pancreatic cystic neoplasms.
    Gut. 2018 Mar 24. pii: gutjnl-2018-316027. doi: 10.1136/gutjnl-2018-316027.
    PubMed     Text format     Abstract available


  33. YANG N, Li B, Pan Y, Tu J, et al
    Hypertriglyceridaemia delays pancreatic regeneration after acute pancreatitis in mice and patients.
    Gut. 2018 Mar 16. pii: gutjnl-2017-315560. doi: 10.1136/gutjnl-2017-315560.
    PubMed     Text format    


    February 2018
  34. ARNES L, Liu Z, Wang J, Maurer HC, et al
    Comprehensive characterisation of compartment-specific long non-coding RNAs associated with pancreatic ductal adenocarcinoma.
    Gut. 2018 Feb 10. pii: gutjnl-2017-314353. doi: 10.1136/gutjnl-2017-314353.
    PubMed     Text format     Abstract available


    January 2018
  35. LEE AYL, Dubois CL, Sarai K, Zarei S, et al
    Cell of origin affects tumour development and phenotype in pancreatic ductal adenocarcinoma.
    Gut. 2018 Jan 23. pii: gutjnl-2017-314426. doi: 10.1136/gutjnl-2017-314426.
    PubMed     Text format     Abstract available


    December 2017
  36. MICHL P, Krug S
    Overcoming immune evasion in pancreatic cancer: the combination matters.
    Gut. 2017 Dec 7. pii: gutjnl-2017-315443. doi: 10.1136/gutjnl-2017-315443.
    PubMed     Text format    


  37. NYWENING TM, Belt BA, Cullinan DR, Panni RZ, et al
    Targeting both tumour-associated CXCR2(+) neutrophils and CCR2(+) macrophages disrupts myeloid recruitment and improves chemotherapeutic responses in pancreatic ductal adenocarcinoma.
    Gut. 2017 Dec 1. pii: gutjnl-2017-313738. doi: 10.1136/gutjnl-2017-313738.
    PubMed     Text format     Abstract available


  38. WU H, Boulling A, Cooper DN, Li ZS, et al
    In vitro and in silico evidence against a significant effect of the SPINK1 c.194G>A variant on pre-mRNA splicing.
    Gut. 2017;66:2195-2196.
    PubMed     Text format    


    November 2017
  39. HUANG L, Jansen L, Balavarca Y, Molina-Montes E, et al
    Resection of pancreatic cancer in Europe and USA: an international large-scale study highlighting large variations.
    Gut. 2017 Nov 20. pii: gutjnl-2017-314828. doi: 10.1136/gutjnl-2017-314828.
    PubMed     Text format     Abstract available


    October 2017
  40. CHOU A, Froio D, Nagrial AM, Parkin A, et al
    Tailored first-line and second-line CDK4-targeting treatment combinations in mouse models of pancreatic cancer.
    Gut. 2017 Oct 28. pii: gutjnl-2017-315144. doi: 10.1136/gutjnl-2017-315144.
    PubMed     Text format     Abstract available


  41. NOTTA F, Hahn SA, Real FX
    A genetic roadmap of pancreatic cancer: still evolving.
    Gut. 2017 Oct 9. pii: gutjnl-2016-313317. doi: 10.1136/gutjnl-2016-313317.
    PubMed     Text format     Abstract available


  42. BANG JY, Hebert-Magee S, Navaneethan U, Hasan MK, et al
    EUS-guided fine needle biopsy of pancreatic masses can yield true histology: results of a randomised trial.
    Gut. 2017 Oct 7. pii: gutjnl-2017-315154. doi: 10.1136/gutjnl-2017-315154.
    PubMed     Text format    


    September 2017
  43. SINGHI AD, McGrath K, Brand RE, Khalid A, et al
    Preoperative next-generation sequencing of pancreatic cyst fluid is highly accurate in cyst classification and detection of advanced neoplasia.
    Gut. 2017 Sep 28. pii: gutjnl-2016-313586. doi: 10.1136/gutjnl-2016-313586.
    PubMed     Text format     Abstract available


  44. TANG XY, Zou WB, Masson E, Hu LH, et al
    The CTRB1-CTRB2 risk allele for chronic pancreatitis discovered in European populations does not contribute to disease risk variation in the Chinese population due to near allele fixation.
    Gut. 2017 Sep 26. pii: gutjnl-2017-315180. doi: 10.1136/gutjnl-2017-315180.
    PubMed     Text format    


  45. HOPPER AD, Campbell JA
    Improving future studies in chronic pancreatitis: a paradigm shift in our understanding?
    Gut. 2017 Sep 22. pii: gutjnl-2017-315067. doi: 10.1136/gutjnl-2017-315067.
    PubMed     Text format    


  46. KROMREY ML, Bulow R, Hubner J, Paperlein C, et al
    Prospective study on the incidence, prevalence and 5-year pancreatic-related mortality of pancreatic cysts in a population-based study.
    Gut. 2017 Sep 6. pii: gutjnl-2016-313127. doi: 10.1136/gutjnl-2016-313127.
    PubMed     Text format     Abstract available


    August 2017
  47. VAN DIJK SM, Hallensleben NDL, van Santvoort HC, Fockens P, et al
    Acute pancreatitis: recent advances through randomised trials.
    Gut. 2017 Aug 24. pii: gutjnl-2016-313595. doi: 10.1136/gutjnl-2016-313595.
    PubMed     Text format     Abstract available


  48. IORIO V, Rosati A, D'Auria R, De Marco M, et al
    Combined effect of anti-BAG3 and anti-PD-1 treatment on macrophage infiltrate, CD8+ T cell number and tumour growth in pancreatic cancer.
    Gut. 2017 Aug 11. pii: gutjnl-2017-314225. doi: 10.1136/gutjnl-2017-314225.
    PubMed     Text format    


  49. SARR MG
    Minimal access necrosectomy: the newest advance of many in the treatment of necrotising pancreatitis.
    Gut. 2017 Aug 10. pii: gutjnl-2017-314660. doi: 10.1136/gutjnl-2017-314660.
    PubMed     Text format    


  50. SELEZNIK GM, Reding T, Peter L, Gupta A, et al
    Development of autoimmune pancreatitis is independent of CDKN1A/p21-mediated pancreatic inflammation.
    Gut. 2017 Aug 3. pii: gutjnl-2016-313458. doi: 10.1136/gutjnl-2016-313458.
    PubMed     Text format     Abstract available


  51. VAN BRUNSCHOT S, Hollemans RA, Bakker OJ, Besselink MG, et al
    Minimally invasive and endoscopic versus open necrosectomy for necrotising pancreatitis: a pooled analysis of individual data for 1980 patients.
    Gut. 2017 Aug 3. pii: gutjnl-2016-313341. doi: 10.1136/gutjnl-2016-313341.
    PubMed     Text format     Abstract available


  52. SINGH VP
    High on drugs: lessons from opiates in pancreatitis.
    Gut. 2017 Aug 1. pii: gutjnl-2017-314506. doi: 10.1136/gutjnl-2017-314506.
    PubMed     Text format    


    July 2017
  53. ROSENDAHL J, Kirsten H, Hegyi E, Kovacs P, et al
    Genome-wide association study identifies inversion in the CTRB1-CTRB2 locus to modify risk for alcoholic and non-alcoholic chronic pancreatitis.
    Gut. 2017 Jul 28. pii: gutjnl-2017-314454. doi: 10.1136/gutjnl-2017-314454.
    PubMed     Text format     Abstract available


    June 2017
  54. SCARPA A, Mafficini A
    Non-coding regulatory variations: the dark matter of pancreatic cancer genomics.
    Gut. 2017 Jun 28. pii: gutjnl-2017-314310. doi: 10.1136/gutjnl-2017-314310.
    PubMed     Text format    


  55. BARLASS U, Dutta R, Cheema H, George J, et al
    Morphine worsens the severity and prevents pancreatic regeneration in mouse models of acute pancreatitis.
    Gut. 2017 Jun 22. pii: gutjnl-2017-313717. doi: 10.1136/gutjnl-2017-313717.
    PubMed     Text format     Abstract available


  56. ZHANG M, Lykke-Andersen S, Zhu B, Xiao W, et al
    Characterising cis-regulatory variation in the transcriptome of histologically normal and tumour-derived pancreatic tissues.
    Gut. 2017 Jun 20. pii: gutjnl-2016-313146. doi: 10.1136/gutjnl-2016-313146.
    PubMed     Text format     Abstract available


  57. GOYAL J, Barkin JA, Barkin JS
    Randomised controlled trial of long-term maintenance corticosteroid therapy in patients with autoimmune pancreatitis.
    Gut. 2017 Jun 10. pii: gutjnl-2017-314460. doi: 10.1136/gutjnl-2017-314460.
    PubMed     Text format    


  58. MASSON E, Chen JM, Cooper DN, Ferec C, et al
    PRSS1 copy number variants and promoter polymorphisms in pancreatitis: common pathogenetic mechanism, different genetic effects.
    Gut. 2017 Jun 10. pii: gutjnl-2017-314443. doi: 10.1136/gutjnl-2017-314443.
    PubMed     Text format    


    May 2017
  59. COSTELLO E
    A metabolomics-based biomarker signature discriminates pancreatic cancer from chronic pancreatitis.
    Gut. 2017 May 24. pii: gutjnl-2016-313665. doi: 10.1136/gutjnl-2016-313665.
    PubMed     Text format    


    March 2017
  60. ZHU H, Lin H, Jin Z, Du Y, et al
    Re-evaluation of the role of lumen-apposing metal stents (LAMS) for pancreatic fl uid collection drainage.
    Gut. 2017 Mar 17. pii: gutjnl-2017-313949. doi: 10.1136/gutjnl-2017-313949.
    PubMed     Text format    


  61. KUJKO AA, Berki DM, Oracz G, Wejnarska K, et al
    A novel p.Ser282Pro CPA1 variant is associated with autosomal dominant hereditary pancreatitis.
    Gut. 2017 Mar 3. pii: gutjnl-2017-313816. doi: 10.1136/gutjnl-2017-313816.
    PubMed     Text format    


    February 2017
  62. SANCHEZ-AREVALO LOBO VJ, Fernandez LC, Carrillo-de-Santa-Pau E, Richart L, et al
    c-Myc downregulation is required for preacinar to acinar maturation and pancreatic homeostasis.
    Gut. 2017 Feb 3. pii: gutjnl-2016-312306. doi: 10.1136/gutjnl-2016-312306.
    PubMed     Text format     Abstract available


    January 2017
  63. WINDSOR JA
    Pancreatic enzyme replacement therapy in chronic pancreatitis: a long way to go.
    Gut. 2017 Jan 27. pii: gutjnl-2016-313455. doi: 10.1136/gutjnl-2016-313455.
    PubMed     Text format    


  64. WILLIAMS E, Beckingham I, El Sayed G, Gurusamy K, et al
    Updated guideline on the management of common bile duct stones (CBDS).
    Gut. 2017 Jan 25. pii: gutjnl-2016-312317. doi: 10.1136/gutjnl-2016-312317.
    PubMed     Text format     Abstract available


  65. MAYERLE J, Kalthoff H, Reszka R, Kamlage B, et al
    Metabolic biomarker signature to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis.
    Gut. 2017 Jan 20. pii: gutjnl-2016-312432. doi: 10.1136/gutjnl-2016-312432.
    PubMed     Text format     Abstract available


  66. STECHER SS, Simon P, Friesecke S, Glitsch A, et al
    Delayed severe bleeding complications after treatment of pancreatic fluid collections with lumen-apposing metal stents.
    Gut. 2017 Jan 12. pii: gutjnl-2016-313562. doi: 10.1136/gutjnl-2016-313562.
    PubMed     Text format    


  67. KNUDSEN ES, Balaji U, Mannakee B, Vail P, et al
    Pancreatic cancer cell lines as patient-derived avatars: genetic characterisation and functional utility.
    Gut. 2017 Jan 10. pii: gutjnl-2016-313133. doi: 10.1136/gutjnl-2016-313133.
    PubMed     Text format     Abstract available


    December 2016
  68. NEMETH BC, Patai AV, Sahin-Toth M, Hegyi P, et al
    Misfolding cationic trypsinogen variant p.L104P causes hereditary pancreatitis.
    Gut. 2016 Dec 23. pii: gutjnl-2016-313451. doi: 10.1136/gutjnl-2016-313451.
    PubMed     Text format    


  69. RYAN BM, Venkatachalapathy SV, Huggett MT
    Safety of lumen-apposing metal stents (LAMS) for pancreatic fluid collection drainage.
    Gut. 2016 Dec 16. pii: gutjnl-2016-313388. doi: 10.1136/gutjnl-2016-313388.
    PubMed     Text format    


  70. DE LA IGLESIA-GARCIA D, Huang W, Szatmary P, Baston-Rey I, et al
    Efficacy of pancreatic enzyme replacement therapy in chronic pancreatitis: systematic review and meta-analysis.
    Gut. 2016 Dec 9. pii: gutjnl-2016-312529. doi: 10.1136/gutjnl-2016-312529.
    PubMed     Text format     Abstract available


  71. DUELL EJ
    Telomere length and pancreatic cancer risk: breaking down the evidence.
    Gut. 2016 Dec 5. pii: gutjnl-2016-313156. doi: 10.1136/gutjnl-2016-313156.
    PubMed     Text format    


    November 2016
  72. TEICH N, Bokemeyer B, Mohl W, Walldorf J, et al
    Blood group B is associated with azathioprine-induced acute pancreatitis in patients with IBD.
    Gut. 2016 Nov 14. pii: gutjnl-2016-313138. doi: 10.1136/gutjnl-2016-313138.
    PubMed     Text format    


  73. LEEDS JS, Nayar MK, Charnley RM, Oppong KW, et al
    Lumen-apposing metal stents for pancreatic fluid collection drainage: may not be business as usual?
    Gut. 2016 Nov 4. pii: gutjnl-2016-313187. doi: 10.1136/gutjnl-2016-313187.
    PubMed     Text format    


  74. HESSMANN E, Johnsen SA, Siveke JT, Ellenrieder V, et al
    Epigenetic treatment of pancreatic cancer: is there a therapeutic perspective on the horizon?
    Gut. 2016 Nov 3. pii: gutjnl-2016-312539. doi: 10.1136/gutjnl-2016-312539.
    PubMed     Text format     Abstract available


    October 2016
  75. BAO Y, Prescott J, Yuan C, Zhang M, et al
    Leucocyte telomere length, genetic variants at the TERT gene region and risk of pancreatic cancer.
    Gut. 2016 Oct 21. pii: gutjnl-2016-312510. doi: 10.1136/gutjnl-2016-312510.
    PubMed     Text format     Abstract available


  76. MACE TA, Shakya R, Pitarresi JR, Swanson B, et al
    IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer.
    Gut. 2016 Oct 21. pii: gutjnl-2016-311585. doi: 10.1136/gutjnl-2016-311585.
    PubMed     Text format     Abstract available


  77. FAN X, Alekseyenko AV, Wu J, Peters BA, et al
    Human oral microbiome and prospective risk for pancreatic cancer: a population-based nested case-control study.
    Gut. 2016 Oct 14. pii: gutjnl-2016-312580. doi: 10.1136/gutjnl-2016-312580.
    PubMed     Text format     Abstract available


  78. HART PA, Chari ST
    Preventing disease relapses in autoimmune pancreatitis with maintenance steroids: are we there yet?
    Gut. 2016 Oct 5. pii: gutjnl-2016-312738. doi: 10.1136/gutjnl-2016-312738.
    PubMed     Text format    


    September 2016
  79. WILLS ES, Drenth JP
    Building pancreatic organoids to aid drug development.
    Gut. 2016 Sep 21. pii: gutjnl-2016-312865. doi: 10.1136/gutjnl-2016-312865.
    PubMed     Text format    


  80. KONG B, Bruns P, Behler NA, Chang L, et al
    Dynamic landscape of pancreatic carcinogenesis reveals early molecular networks of malignancy.
    Gut. 2016 Sep 19. pii: gutjnl-2015-310913. doi: 10.1136/gutjnl-2015-310913.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pancreatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: